INTERNATIONAL PATENT: SPEXIS AG, CEDARS-SINAI MEDICAL CENTER, THE JOHNS HOPKINS UNIVERSITY, THE REGENTS OF THE UNIVERSITY OF MICHIGAN FILES APPLICATION FOR "PHARMACEUTICAL COMBINATION OF CXCR4, PD-1 AND FAK INHIBITORS FOR TREATING CANCER"

GENEVA, April 6 -- SPEXIS AG (Hegenheimermattweg 1254123 Allschwil), CEDARS-SINAI MEDICAL CENTER (8700 Beverly BoulevardLos Angeles, California 90048), THE JOHNS HOPKINS UNIVERSITY (3400 N. Charles StreetBaltimore, Maryland 21218), THE REGENTS OF THE UNIVERSITY OF MICHIGAN (1600 Huron Parkway, 2nd floorAnn Arbor, Michigan 48109-2590) filed a patent application (PCT/EP2024/077021) for "PHARMACEUTICAL COMBINATION OF CXCR4, PD-1 AND FAK INHIBITORS FOR TREATING CANCER" on Sep 26, 2024. With publication no. WO/2025/068346, the details related to the patent application was published on Apr 03, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual...